
Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
AZN | London | GBP | Real-time | |
3LAZ | London | GBP | Real-time | |
3SAZ | London | GBP | Real-time | |
AZNl | BATS Europe | GBP | Delayed | |
AZNs | BATS Europe | SEK | Delayed | |
AZN | NASDAQ | USD | Real-time | |
AZNCF | OTC Markets | USD | Delayed | |
AZNN | Mexico | MXN | Delayed | |
AZN | Stockholm | SEK | Real-time | |
AZN | Frankfurt | EUR | Delayed | |
AZN | TradeGate | EUR | Delayed | |
AZN | Xetra | EUR | Delayed | |
AZNPy | Frankfurt | EUR | Delayed | |
AZN | Buenos Aires | ARS | Delayed |
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Veru Suggested By FDA To Submit Emergency Use Request For Sabizabulin In COVID-19 In a Pre-EUA...
(Reuters) - Investment firm All Blue Capital would be advised by Alan Barge, former oncology head at British drugmaker AstraZeneca (NASDAQ:AZN) Plc, in its bid to acquire drug developer Zymeworks...
By Natalie Grover and Pushkala Aripaka (Reuters) -AstraZeneca's COVID-19 vaccine still has a role to play in the fight against the pandemic, even as sales slow and the company charges more in some...
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Bristol Myers' Oral Heart Disease Drug Scores FDA Approval The FDA has approved Bristol Myers Squibb...
Investing.com - AstraZeneca (NASDAQ:AZN) reported on Friday first quarter earnings that beat analysts' forecasts and revenue that topped expectations. AstraZeneca announced earnings per share of...
AstraZeneca Plc's (NASDAQ: NASDAQ:AZN) total revenue jumped 60% Y/Y at CER to $11.39 billion in Q1 FY22, beating the consensus of $10.99 billion. The growth reflects the contribution of the Alexion...
AstraZeneca (NASDAQ:AZN) reported Q1 EPS of $1.89, $1.06 better than the analyst estimate of $0.83. Revenue for the quarter came in at $11.4 billion versus the consensus estimate of $10.99...
Investing.com - AstraZeneca (NASDAQ:AZN) ADR reported on Friday first quarter earnings that beat analysts' forecasts and revenue that topped expectations. AstraZeneca ADR announced earnings per...
By Laura Sanchez Investing.com - Today, investors focus on important macro data, such as eurozone inflation and GDP in different European countries. We will also keep an eye on the corporate earnings...
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Uranium Energy Corp. (NYSE: UEC) is a "very speculative stock." He added that the stock had a very big run and might get "cut in half or...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review